S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
Free Trial
LON:SBS

Source BioScience (SBS) Share Price, News & Analysis

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)
Free SBS Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
458,233 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
SBS stock logo

About Source BioScience Stock (LON:SBS)

Source BioScience plc is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation.

SBS Stock News Headlines

March 28, 2024 | msn.com
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript
February 3, 2024 | msn.com
Cellectar Biosciences Announces Recent Share Issuance Update
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
January 12, 2024 | msn.com
Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial
December 21, 2023 | markets.businessinsider.com
Bedrock Bioscience Announces Groundbreaking Medical Study Published in Prestigious Journal
November 17, 2023 | marketwatch.com
Twist Bioscience Shares Climb on Strong 4Q, Upbeat Outlook
November 9, 2023 | marketwatch.com
Neurocrine Biosciences Shares Fall After Two Studies Fail to Achieve Desired Results
September 25, 2023 | benzinga.com
Human Microbiome Market size worth USD 1,689.5 Million, Globally, by 2027 at 21.8% CAGR: Verified Market Research®
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
September 1, 2023 | npr.org
TPR: The Source
August 1, 2023 | finanznachrichten.de
Twist Bioscience DNA-Based Tools Now Available in Ireland From MyBio
July 21, 2023 | benzinga.com
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer
July 2, 2023 | msn.com
West End Labs signs first tenant in Graviton Bioscience for new 400K-square-foot life sciences building
June 19, 2023 | markets.businessinsider.com
SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
May 17, 2023 | marketwatch.com
Styrene-Butadiene-Styrene (SBS) Block Copolymer Market 2023: Insights and Strategies | 2031
May 13, 2023 | msn.com
Xenetic Biosciences announces reverse stock split of common stock
May 10, 2023 | marketwatch.com
Sequencing By Synthesis(Sbs) Market Analysis [2023-2030] Understanding the Latest Market Trends
May 9, 2023 | marketwatch.com
Solid Bleached Sulfate (SBS) Board Market in 2030: Insights, Strategies, and Projections
April 18, 2023 | techrepublic.com
6 best open-source kanban boards for managing projects in 2023
March 14, 2023 | lse.co.uk
Source BioScience Agrees GBP62.9 Million Takeover Deal
February 23, 2023 | benzinga.com
On the rise in 2023: Six Arizona bioscience startups
February 22, 2023 | uk.finance.yahoo.com
Clinical Oncology Next Generation Sequencing Global Market Report 2023
February 3, 2023 | marketwatch.com
Twist Bioscience Shares Slide 19%; 2Q Revenue Guidance Below Estimates
January 28, 2023 | benzinga.com
Bioinformatics Services Market is expected to grow from USD 2.8 billion in 2022 to USD 8.7 billion by 2030 : GreyViews
January 12, 2023 | marketwatch.com
Stocks to Watch: Disney, Yield10 Bioscience, KB Home
December 27, 2022 | technews.tmcnet.com
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
December 16, 2022 | marketwatch.com
Oligonucleotides Market Insights : Industry dynamics, New Technologies and Forecast to 2028
See More Headlines
Receive SBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Source BioScience and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Manufacturing
Industry
Electronic Computer Manufacturing
Sub-Industry
N/A
Current Symbol
LON:SBS
CUSIP
N/A
CIK
N/A
Web
www.sabesp.com.br
Phone
+44-115-9739012
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

SBS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Source BioScience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Source BioScience investors own include Anglo American (AAL), Hastings Group Holdings plc (HSTG.L) (HSTG), Renishaw (RSW), Spirent Communications (SPT), Rotork (ROR), Hiscox (HSX), Anglo American (NGLOY), SEB (SKP), discoverIE Group (DSCV) and DiamondCorp (DCP).

How do I buy shares of Source BioScience?

Shares of SBS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SBS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The “Perfect Storm” for Gold
Gold Safe Exchange
Strange new buyer driving up gold
Stansberry Research
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
SHOCKING Crypto Leak…
Crypto 101 Media
Top 5 AI Stocks to Buy for 2024
Market Moving Trends